Long COVID Linked to Increased Uveitis Risk Among Unvaccinated Individuals

Researchers report that unvaccinated individuals with long COVID are more likely to develop new-onset anterior uveitis compared to their unvaccinated counterparts, emphasizing the importance of vaccination in preventing post-viral ocular inflammation. Photo: Michael Trottini, OD, and Candice Tolud, OD. Click image to enlarge. A new population-based, retrospective cohort study has found that unvaccinated individuals with long COVID face a significantly higher risk of developing new-onset uveitis, particularly anterior uveitis. In contrast, this increased risk was not observed in vaccinated individuals, suggesting that COVID-19 vaccination may play a protective role against post-infectious ocular inflammation. The research, published in Journal of Ophthalmic Inflammation and Infection, offers valuable insight for optometrists managing this unique patient population. Long COVID, also referred to as post-acute sequelae of COVID-19, is described by the World Health Organization as the persistence or emergence of new symptoms three months after an initial SARS-CoV-2 infection, with those symptoms continuing for a minimum duration of two months. This condition has been linked to ongoing disturbances in immune function, including reductions in CD4+ and CD8+ effector T-cell populations and abnormal long-term elevations of pro-inflammatory mediators, according to the study authors. This analysis used an aggregate healthcare database (TriNetX) that includes data from more than 127 million patients from 95 international healthcare organizations. The researchers compared four cohorts based on vaccination status and long COVID diagnosis: (1) unvaccinated individuals with the condition, (2) unvaccinated individuals without it, (3) vaccinated individuals with long covid and (4) vaccinated individuals without it. Anyone with a history of uveitis before their initial COVID-19 diagnosis was excluded from the study. The primary goal was to determine the risk of new-onset uveitis at one and two years following long COVID diagnosis.The results showed that unvaccinated individuals with long COVID had a significantly higher risk of developing new uveitis compared to unvaccinated individuals who did not develop the condition. At one year after diagnosis, the adjusted hazard ratio (aHR) was 2.01 and at two years it was 1.60. The strongest association was observed for anterior uveitis, with an aHR of 1.96 at one year and 1.59 at two years. Other uveitis subtypes did not show a statistically significant increase in risk among this group.Conversely, vaccinated individuals with long COVID did not experience an elevated risk of developing uveitis when compared with vaccinated individuals who did not have the condition. For these groups, the adjusted hazard ratios were 0.95 at one year and 0.97 at two years.“While our study did not demonstrate vaccination to increase the risk of uveitis among long COVID patients, an important consideration established by prior research has demonstrated that patient anxiety and concern regarding vaccination can influence the perception and reporting of symptoms, potentially amplifying subjective symptom severity without objective disease progression,” the study authors wrote in their paper, while noting that this underscores the value of addressing patient concerns and providing psychological support when discussing vaccination. “Alleviating anxiety not only enhances patient mental well-being but may also mitigate the perception of physical symptoms, fostering greater confidence in vaccination and adherence to care plans,” they concluded. Click here for the journal source. Dihan QA, Alshammari N, Elhusseiny AM, et al. Long COVID and the development of new-onset uveitis: a large database study. J Ophthal Inflamm Infect. 2025;15:79.  This article was developed by the editorial staff in conjunction with experts in the field. In the process, AI may have been among the editorial tools used to meet the goals of human editors, who approved all content.